APA (7th ed.) Citation

Dummer, R., Daud, A., Eigentler, T., Evans, T., Henry, J., Hodi, F., . . . Mehnert, J. (2024). 1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors. Annals of Oncology, 35, S709. https://doi.org/10.1016/j.annonc.2024.08.1129

Chicago Style (17th ed.) Citation

Dummer, R., et al. "1071TiP Phase I Study of the Investigational CD228 X 4-1BB Costimulatory Antibody Anticalin Bispecific SGN-BB228 (PF-08046049) in Advanced Melanoma and Other Solid Tumors." Annals of Oncology 35 (2024): S709. https://doi.org/10.1016/j.annonc.2024.08.1129.

MLA (9th ed.) Citation

Dummer, R., et al. "1071TiP Phase I Study of the Investigational CD228 X 4-1BB Costimulatory Antibody Anticalin Bispecific SGN-BB228 (PF-08046049) in Advanced Melanoma and Other Solid Tumors." Annals of Oncology, vol. 35, 2024, p. S709, https://doi.org/10.1016/j.annonc.2024.08.1129.